Matches in SemOpenAlex for { <https://semopenalex.org/work/W3210761091> ?p ?o ?g. }
- W3210761091 endingPage "1528" @default.
- W3210761091 startingPage "1519" @default.
- W3210761091 abstract "This study aimed to evaluate whether combined therapy with PD-1 blockade (anti-PD-1) and radiofrequency ablation (RFA) is superior to RFA monotherapy for recurrent hepatocellular carcinoma (HCC).A total of 127 patients who underwent anti-PD-1 plus RFA treatment (n = 41) or RFA alone (n = 86) for recurrent HCC were included in this retrospective study. A matched cohort comprising 40 patients from each group was selected after propensity score matching analysis. Clinical data including post-RFA HCC recurrence (primary endpoint), overall survival (OS) (secondary endpoint), adverse events, and toxic effects were retrospectively analyzed.The 1-year recurrence-free survival rates for the anti-PD-1 plus RFA and RFA groups were 32.5% and 10.0% after propensity score matching. There were statistically significant differences between the two groups in terms of the recurrence-free survival rate (p = 0.001) and OS rate (p = 0.016). Tumor number, tumor-node metastasis (TNM) stage, antiviral therapy, and anti-PD-1 treatment were demonstrated to be important factors associated with 1-year recurrence-free survival probability by univariate and multivariate analyses. Univariate and multivariate analyses demonstrated that tumor number, TNM stage and anti-PD-1 treatment were significant prognostic factors for OS. RFA treatment-related adverse events included pleural effusions that require drainage and a mild or moderate increase in body temperature. Grade 3 or higher events related to anti-PD-1 treatment occurred in 12.8% (6) of patients and were infrequent.Combination therapy with anti-PD-1 plus RFA was superior to RFA alone in improving survival in patients with recurrent HCC." @default.
- W3210761091 created "2021-11-08" @default.
- W3210761091 creator A5000984825 @default.
- W3210761091 creator A5012955908 @default.
- W3210761091 creator A5018866860 @default.
- W3210761091 creator A5028702225 @default.
- W3210761091 creator A5035131101 @default.
- W3210761091 creator A5042456385 @default.
- W3210761091 creator A5048924658 @default.
- W3210761091 creator A5088882767 @default.
- W3210761091 date "2021-01-01" @default.
- W3210761091 modified "2023-10-18" @default.
- W3210761091 title "Combination therapy with PD-1 blockade and radiofrequency ablation for recurrent hepatocellular carcinoma: a propensity score matching analysis" @default.
- W3210761091 cites W1922412259 @default.
- W3210761091 cites W1987073180 @default.
- W3210761091 cites W2015093946 @default.
- W3210761091 cites W2030694165 @default.
- W3210761091 cites W2032166347 @default.
- W3210761091 cites W2049010867 @default.
- W3210761091 cites W2052727153 @default.
- W3210761091 cites W2054211598 @default.
- W3210761091 cites W2065543285 @default.
- W3210761091 cites W2092605209 @default.
- W3210761091 cites W2096998881 @default.
- W3210761091 cites W2109485845 @default.
- W3210761091 cites W2110861755 @default.
- W3210761091 cites W2122924344 @default.
- W3210761091 cites W2132449054 @default.
- W3210761091 cites W2133208667 @default.
- W3210761091 cites W2155363135 @default.
- W3210761091 cites W2156901310 @default.
- W3210761091 cites W2160834915 @default.
- W3210761091 cites W2169808388 @default.
- W3210761091 cites W2172053487 @default.
- W3210761091 cites W2288738065 @default.
- W3210761091 cites W2401804267 @default.
- W3210761091 cites W2599658522 @default.
- W3210761091 cites W2610585553 @default.
- W3210761091 cites W2684250302 @default.
- W3210761091 cites W2709770196 @default.
- W3210761091 cites W2752528156 @default.
- W3210761091 cites W2791667186 @default.
- W3210761091 cites W2933314153 @default.
- W3210761091 cites W2937283039 @default.
- W3210761091 cites W2963686803 @default.
- W3210761091 cites W2969802526 @default.
- W3210761091 cites W2977722669 @default.
- W3210761091 cites W2990563906 @default.
- W3210761091 cites W2990602950 @default.
- W3210761091 cites W3025022288 @default.
- W3210761091 cites W3028964057 @default.
- W3210761091 cites W3033218405 @default.
- W3210761091 cites W3134417868 @default.
- W3210761091 doi "https://doi.org/10.1080/02656736.2021.1991011" @default.
- W3210761091 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34702122" @default.
- W3210761091 hasPublicationYear "2021" @default.
- W3210761091 type Work @default.
- W3210761091 sameAs 3210761091 @default.
- W3210761091 citedByCount "19" @default.
- W3210761091 countsByYear W32107610912021 @default.
- W3210761091 countsByYear W32107610912022 @default.
- W3210761091 countsByYear W32107610912023 @default.
- W3210761091 crossrefType "journal-article" @default.
- W3210761091 hasAuthorship W3210761091A5000984825 @default.
- W3210761091 hasAuthorship W3210761091A5012955908 @default.
- W3210761091 hasAuthorship W3210761091A5018866860 @default.
- W3210761091 hasAuthorship W3210761091A5028702225 @default.
- W3210761091 hasAuthorship W3210761091A5035131101 @default.
- W3210761091 hasAuthorship W3210761091A5042456385 @default.
- W3210761091 hasAuthorship W3210761091A5048924658 @default.
- W3210761091 hasAuthorship W3210761091A5088882767 @default.
- W3210761091 hasBestOaLocation W32107610911 @default.
- W3210761091 hasConcept C126322002 @default.
- W3210761091 hasConcept C141071460 @default.
- W3210761091 hasConcept C143998085 @default.
- W3210761091 hasConcept C144301174 @default.
- W3210761091 hasConcept C146357865 @default.
- W3210761091 hasConcept C151730666 @default.
- W3210761091 hasConcept C167135981 @default.
- W3210761091 hasConcept C168563851 @default.
- W3210761091 hasConcept C17923572 @default.
- W3210761091 hasConcept C197934379 @default.
- W3210761091 hasConcept C203092338 @default.
- W3210761091 hasConcept C2777377203 @default.
- W3210761091 hasConcept C2778019345 @default.
- W3210761091 hasConcept C2778902805 @default.
- W3210761091 hasConcept C38180746 @default.
- W3210761091 hasConcept C50382708 @default.
- W3210761091 hasConcept C71924100 @default.
- W3210761091 hasConcept C86803240 @default.
- W3210761091 hasConcept C90924648 @default.
- W3210761091 hasConceptScore W3210761091C126322002 @default.
- W3210761091 hasConceptScore W3210761091C141071460 @default.
- W3210761091 hasConceptScore W3210761091C143998085 @default.
- W3210761091 hasConceptScore W3210761091C144301174 @default.
- W3210761091 hasConceptScore W3210761091C146357865 @default.
- W3210761091 hasConceptScore W3210761091C151730666 @default.
- W3210761091 hasConceptScore W3210761091C167135981 @default.